Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 283,055 | 235,133 | 175,513 | 134,030 | 45,605 |
| Cost of Goods | 32,665 | 28,248 | 14,148 | 5,664 | 1,091 |
| Gross Profit | 250,390 | 206,885 | 161,365 | 128,366 | 44,514 |
| Operating Expenses | 143,829 | 188,466 | 253,056 | 239,836 | 225,249 |
| Operating Income | 106,561 | 18,419 | -91,691 | -111,470 | -180,735 |
| Interest Expense | 4,330 | 4,835 | 2,775 | N/A | N/A |
| Other Income | 11,926 | -6,136 | 16,997 | 5,118 | 529 |
| Pre-tax Income | 114,157 | 7,448 | -77,469 | -106,352 | -180,206 |
| Income Tax | -173,045 | 1,696 | 551 | 1,828 | 760 |
| Net Income Continuous | 287,202 | 5,752 | -78,020 | -108,180 | -180,966 |
| Net Income | $287,202 | $5,752 | $-78,020 | $-108,180 | $-180,966 |
| EBITDA(a) | $137,936 | $31,728 | $-63,047 | $-108,764 | $-177,974 |